Product NDC: | 11994-427 |
Proprietary Name: | Thallous Chloride Tl 201 |
Non Proprietary Name: | THALLOUS CHLORIDE TL-201 |
Active Ingredient(s): | 2 mCi/mL & nbsp; THALLOUS CHLORIDE TL-201 |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 11994-427 |
Labeler Name: | Lantheus Medical Imaging, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA017806 |
Marketing Category: | NDA |
Start Marketing Date: | 19771219 |
Package NDC: | 11994-427-26 |
Package Description: | 3.3 mL in 1 VIAL (11994-427-26) |
NDC Code | 11994-427-26 |
Proprietary Name | Thallous Chloride Tl 201 |
Package Description | 3.3 mL in 1 VIAL (11994-427-26) |
Product NDC | 11994-427 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | THALLOUS CHLORIDE TL-201 |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19771219 |
Marketing Category Name | NDA |
Labeler Name | Lantheus Medical Imaging, Inc. |
Substance Name | THALLOUS CHLORIDE TL-201 |
Strength Number | 2 |
Strength Unit | mCi/mL |
Pharmaceutical Classes | Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] |